RCEL AVITA Medical Inc

Price (delayed)

$4.61

Market cap

$141.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.56

Enterprise value

$181.69M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 45
Relative Valuation: Rel. Valuation: 21
Relative Profitability: Rel. Profitability: 28

AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical's patented and proprietary collection ...

Highlights
The company's EPS rose by 29% YoY and by 10% QoQ
The net income has grown by 21% YoY and by 7% from the previous quarter
RCEL's quick ratio has dropped by 78% year-on-year and by 18% since the previous quarter
AVITA Medical's equity has decreased by 39% QoQ

Key stats

What are the main financial stats of RCEL

RCEL stock price

How has the AVITA Medical stock price performed over time
Intraday
0%
1 week
-9.61%
1 month
16.71%
1 year
-22.91%
YTD
33.62%
QTD
11.62%

Financial performance

How have AVITA Medical's revenue and profit performed over time
Revenue
$72.35M
Gross profit
$58.86M
Operating income
-$39.51M
Net income
-$45.34M
Gross margin
81.4%
Net margin
-62.7%
RCEL's operating margin is up by 24% YoY and by 8% from the previous quarter
The operating income has grown by 23% YoY and by 7% from the previous quarter
The net income has grown by 21% YoY and by 7% from the previous quarter
RCEL's net margin is up by 21% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does RCEL's price correlate with its fundamentals

Growth

What is AVITA Medical's growth rate over time

Valuation

What is AVITA Medical stock price valuation
P/E
N/A
P/B
N/A
P/S
1.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
The company's EPS rose by 29% YoY and by 10% QoQ
AVITA Medical's equity has decreased by 39% QoQ
The P/S is 65% below the 5-year quarterly average of 5.5 but 15% above the last 4 quarters average of 1.7

Efficiency

How efficient is AVITA Medical business performance
The ROIC has plunged by 195% YoY and by 44% from the previous quarter
The company's return on sales rose by 23% YoY and by 9% QoQ
The return on assets has declined by 10% year-on-year

Dividends

What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RCEL.

Financial health

How did AVITA Medical financials performed over time
The total assets is 31% smaller than the total liabilities
AVITA Medical's current ratio has shrunk by 78% YoY and by 18% QoQ
RCEL's quick ratio has dropped by 78% year-on-year and by 18% since the previous quarter
RCEL's debt to equity has soared by 78% year-on-year and by 23% since the previous quarter
AVITA Medical's equity has decreased by 39% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.